论文部分内容阅读
目的：探讨应用酒石酸美托洛尔治疗慢性充血性心力衰竭的临床疗效。方法选取我院心内科慢性充血性心力衰竭患者50例，将其分为A、B两组。A组25例患者使用常规药物进行针对性治疗；B组患者在A组基础上联合使用酒石酸美托洛尔进行治疗。结果 B组患者总有效率为96.0%，明显高于A组76.0%，差异有统计学意义（P＜0.05）；治疗后心功能指标B组患者改善情况明显优于A组（P＜0.05）；左心室重构及心功能各项指标B组均优于A组（P＜0.05）。结论应用酒石酸美托洛尔对慢性充血性心衰进行治疗疗效确切。能够有效提高左心室收缩功能，减少心室容量并降低质量，还能够改善心脏形状，阻止心功能进一步恶化及心室重构，可有效改善患者预后情况并提高生活质量。“,”Objective To investigate the clinical curative effect of metoprolol tartrate in treating chronic congestive heart failure.Methods Take the Department of Cardiology in our hospital, 50 cases of patients with chronic congestive heart failure,which can be divided into A,B two groups.A group of 25 patients using conventional drugs for targeted treatment;group B patients in the A group based on the combined use of metoprolol tartaric acid treatment.Results B group of patients,the total effective rate was 96%,significantly higher than that of A group was 76%,the difference was statistical y significant (P<0.05);after treatment,heart function indexes of patients in the B group significantly better than group A (P<0.05);left ventricular remodeling and heart function indexes of B group than in A group (P<0.05). Conclusion Metoprolol tartaric acid on chronic congestive heart failure were treated with curative effect.It can effectively improve the left ventricular systolic function,reduce ventricular volume and lower quality,but also can improve the heart shape,to prevent further deterioration of cardiac function and ventricular remodeling,which can effectively improve the prognosis of patients and improve the quality of life.